What is the Prognosis for HER2-Positive Cancer Patients?
The prognosis for HER2-positive cancer patients has improved dramatically with the advent of targeted therapies. Prior to the availability of these treatments, HER2-positive cancers were associated with a poor prognosis. However, with therapies like trastuzumab and pertuzumab, patients now have significantly better survival rates and quality of life.